Marcela V. Maus, M.d.,ph.d.

This study tested whether adding a drug called anakinra to a powerful cell therapy (CAR-T) could reduce severe brain-related side effects in patients with lymphoma that has returned or resisted treatment. The main goal was to see if this combination made the CAR-T treatment safer…